Skip to main content
The BMJ logoLink to The BMJ
. 2003 Jan 11;326(7380):75.

Minerva

PMCID: PMC139931

“Stibogluconate, which is used to treat cutaneous leishmaniasis of the new world, is not an arsenic based compound, as stated in the text accompanying the Minerva picture on p 1122 in the issue of 9 November; it is an antimony based compound.”


Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES